Massive drug showdown: can a new pill beat river blindness for good?

NCT ID NCT07145736

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study compares two drugs, ivermectin and moxidectin, to see which works better at controlling river blindness and other common infections like intestinal worms and scabies in Angola. Over 52,000 people in 20 village groups will receive one of the drugs once a year for four years. The goal is to find the best way to reduce these diseases in the community and help guide global treatment policies.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ASCARIS LUMBRICOIDES INFECTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Villages in Andulo and Nharea Municipalities

    RECRUITING

    Andulo, Bíe Province, Angola

More trials for these conditions

Other studies related to the condition(s) this trial covers.